NCT05712148 Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa Status COMPLETED Phase PHASE1/PHASE2
NCT05589714 Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants Status RECRUITING Phase N/A
NCT05573984 Natural History of PRPF31 Mutation-Associated Retinal Dystrophy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05413148 The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa Status UNKNOWN Phase PHASE2/PHASE3
NCT05392751 Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa Status TERMINATED Phase PHASE1/PHASE2
NCT05282953 A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS) Status COMPLETED Phase PHASE1/PHASE2
NCT05258032 Structural and Functional Characterization of Rare Ocular Diseases Status RECRUITING Phase N/A
NCT05203939 Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05176717 Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) Status TERMINATED Phase PHASE2/PHASE3
NCT05158296 Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) Status TERMINATED Phase PHASE2/PHASE3
NCT05147701 Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION Status RECRUITING Phase PHASE1
NCT05085964 An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa Status TERMINATED Phase PHASE2
NCT04945772 Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] Status COMPLETED Phase PHASE2
NCT04925687 Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa Status COMPLETED Phase PHASE1